Company / Shares Outstanding
Gilead Sciences Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.2B
FY2025
5-year range
1.2B / 1.3B
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#8 of 212
Health Care
What the data says
Among 212 Health Care companies, Gilead Sciences is in the bottom 4% for shares outstanding.
Based on SEC 10-K filings.
1246000000.00 in FY2025 with a 5-year CAGR of -0.3%. Top quartile in the Health Care sector.
Remained stable around 1246000000.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 212This company 1.2B Sector average 306.7M
▼
+306.2% above sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 0.0% year-over-year.
- Ranks #8 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2016.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.2B | +0.0% |
| FY2024 | 1.2B | -0.1% |
| FY2023 | 1.2B | -0.6% |
| FY2022 | 1.3B | +0.0% |
| FY2021 | 1.3B | -0.9% |
| FY2020 | 1.3B | -1.2% |
| FY2019 | 1.3B | -2.0% |
| FY2018 | 1.3B | -0.2% |
| FY2017 | 1.3B | -7.9% |
| FY2016 | 1.4B | -5.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026